“Leading global health experts told Capitol Hill lawmakers [Friday] that the fight against malaria is at a turning point, during a hearing on the U.S. role in combating malaria globally,” held by the House Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations, GlobalPost’s “Global Pulse”…
Access to Health Services
“South Africa’s Health Minister Aaron Motsoaledi announced on Monday the launch of a new single-dose combination antiretroviral [ARV] drug that will cost just 89 rand a month ($10) per patient, potentially revolutionizing AIDS treatment in the country,” Salon reports (McDonough, 4/9). “The new pill will be introduced this month to…
“[T]he impact of [a decision by the Supreme Court in India to disallow a new patent for an updated version of Novartis' cancer drug Glivec] will likely be broader than just that issue, escalating a long-simmering fight over patented cancer medications in emerging markets,” Thomas Bollyky, senior fellow for global health,…
This Medecins Sans Frontieres (MSF) special report highlights the top 10 stories of 2011 regarding access to essential medicines, according to MSF. The list includes the findings of the HPTN 052 clinical trial, which “show that providing people with HIV treatment early not only saves their lives but can reduce the risk…
The U.S. Food and Drug Administration’s approval of the tuberculosis (TB) drug Sirturo, also known as bedaquiline, “appears to be just the first step in an exciting renaissance for TB drug development,” Mark Harrington, executive director of Treatment Action Group (TAG), writes in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog. “Another new drug, delamanid, is currently in late clinical trials and has been submitted to the European Medicines Agency for review as a treatment for [multidrug-resistant (MDR)] TB,” he notes. Harrington concludes, “It’s an exciting time for TB treatment, but much more needs to be done and more resources are needed. We need to focus not only on the discovery and development of new drugs, but also on ensuring that news drugs are delivered to those who need them and in combinations that can prevent the emergence of new types of drug resistance” (12/28).
7 More Health Workers Killed In Pakistan In Attacks Suspected To Be Linked To Murders Of Polio Vaccinators
“Gunmen ambushed and shot dead six Pakistani women aid workers and a male doctor on Tuesday, police said, and the charity they worked for said it suspected the attacks were linked to recent murders of polio vaccination workers,” Reuters reports. “Two weeks ago, gunmen killed nine health workers taking part in a national polio vaccination drive in a series of attacks,” the news agency notes (Ahmad/Houreld, 1/1). The murders of the polio workers “brought the work of 225,000 vaccinators to a standstill,” the New York Times writes, adding, “Polio eradication officials have promised to regroup and try again. But first they must persuade the killers to stop shooting workers and even guarantee safe passage.” The newspaper examines the history of resistance to polio vaccination campaigns in Pakistan, Afghanistan, Nigeria, and Mali (McNeil, 12/24).
“Thanks to a herculean effort by health advocates, 78 percent of children in low-income countries receive the basic set of childhood vaccines, covering diphtheria, tetanus, pertussis, hepatitis B and haemophilus influenza,” a Bloomberg View editorial states. However, “[t]his campaign will be disrupted, and lives lost, if immunization critics win their latest battle for an international ban on a vaccine component” — thimerosal, a mercury-containing organic compound — “that has proved to be safe time and time again,” the editorial writes, noting, “Groups such as the Coalition for Mercury-Free Drugs and the Coalition for SafeMinds are pressing their case before the United Nations Environmental Program [UNEP] meets on Jan. 13 to prepare a global treaty reducing mercury use.”
“The Philippine President has signed into law a family-planning bill that was blocked by the Catholic Church for more than a decade,” Al Jazeera reports (12/28). “President Benigno Aquino III signed into a law a bill that promotes contraception and sex education in schools,” the Wall Street Journal writes, adding, “On Saturday, a deputy presidential spokeswoman confirmed in a statement that Mr. Aquino had quietly signed the act into law on Dec. 21, and it will take effect in January, guaranteeing contraceptives will be available to the poorest Filipinos” (Sandique-Carlos, 12/29).
Several newspapers published opinion pieces regarding the recent murders of polio vaccination workers in Pakistan. The following summarizes two opinion pieces and one editorial on the issue.
“The U.S. Food and Drug Administration [on Monday] approved Johnson & Johnson’s drug to treat a form of resistant tuberculosis that is uncommon in the U.S. but growing globally,” the Wall Street Journal reports. “The drug, Sirturo, will treat patients with multidrug-resistant tuberculosis, or MDR-TB, a possibly fatal disease that affects as many as 630,000 people worldwide who can’t be cured with existing therapies alone,” the newspaper notes (Walker/Tadena, 1/2).